MEKAYLA KIRT: Open Payments
NPI 1437843968 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 8 payments from 4 companies in 2025. Trend: 2023 $46 · 2024 $161 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Novo Nordisk Inc | 5 | $86 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| ABBVIE INC. | 1 | $15 |
Products named: TEZSPIRE, Wegovy, SHINGRIX, Ozempic, VRAYLAR.
Industry payments across GA — which companies pay providers there.
